Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avadel Pharmaceuticals Plc ADR (AVDL)

Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avadel Pharmaceuticals Plc ADR 10 EARLSFORT TERRACE DUBLIN L2 D02 T380 IRL

www.avadel.com P: 353-1901-5201

Description:

Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.

Key Statistics

Overview:

Market Capitalization, $K 1,566,982
Enterprise Value, $K 1,535,862
Shares Outstanding, K 90,577
Annual Sales, $ 27,960 K
Annual Net Income, $ -160,280 K
Last Quarter Sales, $ 19,450 K
Last Quarter Net Income, $ -28,790 K
EBIT, $ -137,850 K
EBITDA, $ -136,080 K
60-Month Beta 1.60
% of Insider Shareholders 4.00%
% of Institutional Shareholders 69.19%
Float, K 86,954
% Float 96.00%
Short Volume Ratio 0.39

Growth:

1-Year Return 63.98%
3-Year Return 130.67%
5-Year Return 1,404.35%
5-Year Revenue Growth -72.93%
5-Year Earnings Growth 6.03%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 03/04/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -1.91
EPS Growth vs. Prev Qtr 21.95%
EPS Growth vs. Prev Year 27.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AVDL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -198.06%
Return-on-Assets % -84.51%
Profit Margin % -573.25%
Debt/Equity 0.00
Price/Sales 56.13
Price/Cash Flow N/A
Price/Book 17.80
Book Value/Share 0.98
Interest Coverage -15.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar